BLOG / 🇺🇸 United States · · daily

All HHS Contracts — March 19, 2026

All HHS Contracts

By Gunpowder Editorial ·

2 total filings analysed

Executive Summary

Two bullish HHS contracts totaling $414.7M obligated (potential $670.6M with options) signal multi-year revenue stability for health services providers via cost-plus structures minimizing risk. Wisconsin Physicians Service dominates with $319M CMS Medicare admin award, while Charles River adds $96M NIH preclinical support, highlighting HHS outsourcing trends. Unexercised options offer $252M upside amid extensions to 2028-2029.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior All HHS Contracts digest from March 14, 2026.

Investment Signals (2)

  • HHS cost-plus awards lock in low-risk revenue (HIGH)

    Both contracts use cost-plus pricing with $414.7M obligated and outlays of $241M, providing visibility through 2026+ amid full competition wins.

  • Medicare admin and preclinical services expansion (HIGH)

    CMS $319M award to nonprofit insurer and NIH $96M to lab firm underscore demand for outsourced admin and research support services.

Risk Flags (2)

  • Execution [MEDIUM RISK]

    Performance fees and unexercised options ($252M total) could limit full value capture if milestones missed.

  • Regulatory [MEDIUM RISK]

    Budget shifts or non-extension beyond 2026-2027 could truncate periods to 2028-2029 potentials.

Opportunities (2)

  • $252M unexercised options across contracts offer near-term revenue expansion.

  • HHS extensions to 2028-2029 signal multi-year backlog growth in admin and lab services.

Sector Themes (2)

  • Both awards use low-risk pricing for Medicare admin (NAICS 524114) and facilities support (NAICS 561210), with 80%+ unexercised option value.

  • Dominant $319M CMS award vs. $96M NIH shows Medicare admin scale exceeding research support.

Watch List (2)

  • 👁

    {"entity"=>"Wisconsin Physicians Service Insurance Corp.", "reason"=>"$319M obligation (66% of period total) with $167M options; nonprofit stability via CMS.", "trigger"=>"Option exercises or 2026 extension to 2028"}

  • 👁

    {"entity"=>"Charles River Laboratories, Inc.", "reason"=>"$96M NIH award with $89M options and 43% outlay progress signals preclinical momentum.", "trigger"=>"Full option exercise or 2027 extension to 2029"}

Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 2 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: All HHS Contracts

🇺🇸 More from United States

View all →